Bristol-Myers Squibb Co
DUS:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
DUS:BRM
|
US |
|
T
|
Toyota Motor Corp
SWB:TOM
|
JP |
|
M
|
Microsoft Corp
DUS:MSF
|
US |
|
C
|
Capital One Financial Corp
XMUN:CFX
|
US |
|
Spruce Biosciences Inc
OTC:SPRB
|
US |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BRM is 55.009 EUR with a low forecast of 29.053 EUR and a high forecast of 68.437 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
55.009
EUR
According to Wall Street analysts, the average 1-year price target for BRM is 55.009 EUR with a low forecast of 29.053 EUR and a high forecast of 68.437 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 3 years is -5%.
What is the Gross Profit forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is -5%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 3 years is -5%.
What is the Pre-Tax Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 11%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 17%.
